Livio Luongo Selected Research

metabotropic glutamate receptor 8

1/2020	The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum.
1/2017	Nociception modulation by supraspinal group III metabotropic glutamate receptors.
6/2014	Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions.
3/2011	Metabotropic glutamate receptor subtype 8 in the amygdala modulates thermal threshold, neurotransmitter release, and rostral ventromedial medulla cell activity in inflammatory pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Livio Luongo Research Topics

Disease

42	Pain (Aches) 01/2022 - 05/2008
31	Neuralgia (Stump Neuralgia) 01/2022 - 02/2007
23	Hyperalgesia 01/2022 - 02/2007
12	Chronic Pain 01/2021 - 08/2010
10	Inflammation (Inflammations) 06/2022 - 01/2011
6	Cognitive Dysfunction 01/2021 - 06/2015
4	Brain Concussion (Cerebral Concussion) 01/2020 - 01/2017
3	Mood Disorders (Mood Disorder) 01/2022 - 01/2017
2	Body Weight (Weight, Body) 01/2022 - 01/2019
2	Peripheral Nerve Injuries 01/2021 - 01/2011
2	Hypersensitivity (Allergy) 01/2016 - 03/2013
2	Obesity 01/2016 - 01/2016
2	Osteoporosis 12/2014 - 05/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022
1	Hemorrhage 01/2022
1	Weight Gain 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 03/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2021
1	Keratitis 02/2021
1	Cytokine Release Syndrome 02/2021
1	Chronic Disease (Chronic Diseases) 02/2021
1	COVID-19 01/2021
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Cancer Pain 01/2021
1	Neurobehavioral Manifestations 01/2021
1	Vitamin D Deficiency 01/2020
1	Catalepsy 12/2019

Drug/Important Bio-Agent (IBA)

12	Formaldehyde (Formol)FDA Link 02/2021 - 08/2010
11	Analgesics (Analgesic Drugs)IBA 01/2022 - 03/2008
9	Glutamic Acid (Glutamate)FDA Link 01/2021 - 03/2008
7	EndocannabinoidsIBA 01/2020 - 05/2011
6	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2022 - 08/2010
6	palmidrolIBA 01/2022 - 01/2011
6	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020 - 03/2011
5	metabotropic glutamate receptor 7IBA 01/2020 - 09/2013
5	CannabinoidsIBA 12/2019 - 08/2010
5	CarrageenanIBA 09/2019 - 03/2011
5	LigandsIBA 01/2017 - 08/2010
4	CB2 Cannabinoid ReceptorIBA 06/2022 - 05/2011
4	Opioid Analgesics (Opioids)IBA 01/2021 - 05/2009
4	metabotropic glutamate receptor 8IBA 01/2020 - 03/2011
3	2-pentadecyl-2-oxazolineIBA 01/2022 - 01/2020
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2021 - 01/2015
3	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 03/2011
3	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 11/2012
3	TRPV1 receptorIBA 01/2016 - 05/2009
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016 - 12/2009
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022 - 01/2021
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 02/2014
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2022 - 01/2021
2	Vitamin D FDA LinkGeneric 03/2021 - 01/2020
2	CytokinesIBA 02/2021 - 01/2019
2	Buprenorphine (Subutex)FDA LinkGeneric 01/2021 - 01/2021
2	Adenosine KinaseIBA 06/2018 - 01/2015
2	EnzymesIBA 01/2018 - 05/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2017
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2018 - 01/2015
2	Peptides (Polypeptides)IBA 01/2018 - 01/2017
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017 - 03/2011
2	D-Aspartic Acid (D Aspartate)IBA 01/2017 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2011
2	PlasticsIBA 03/2013 - 01/2011
2	salvinorin AIBA 08/2012 - 09/2011
2	Serotonin (5 Hydroxytryptamine)IBA 03/2011 - 01/2011
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022
1	LuteolinIBA 01/2022
1	cinnabarinic acidIBA 01/2022
1	Neuroprotective AgentsIBA 03/2021
1	1,25-dihydroxyvitamin DIBA 03/2021
1	Lipid AIBA 02/2021
1	Glucosamine (Dona)IBA 02/2021
1	NF-kappa B (NF-kB)IBA 02/2021
1	GlycolipidsIBA 02/2021
1	MonosaccharidesIBA 02/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2021
1	Prostaglandins AIBA 02/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	VaccinesIBA 01/2021
1	N-oleoylglycineIBA 01/2020
1	anandamide (arachidonylethanolamide)IBA 01/2020
1	Dronabinol (THC)FDA LinkGeneric 12/2019
1	erucylphosphocholineIBA 09/2019
1	Glucose (Dextrose)FDA LinkGeneric 09/2019
1	Sweetening Agents (Sweeteners)IBA 09/2019
1	amidaseIBA 01/2019
1	SphingolipidsIBA 01/2019
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2019
1	Hydroxyl RadicalIBA 01/2019
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2019
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	KetonesIBA 01/2019
1	Carboxylic AcidsIBA 01/2019
1	Dimethyl FumarateIBA 01/2019

Therapy/Procedure

6	Therapeutics 01/2019 - 03/2008
4	Analgesia 12/2019 - 12/2009
1	Intraperitoneal Injections 01/2019